{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Haerbin",
      "state": "N/A",
      "country": "China",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98438",
      "recalling_firm": "Harbin Jixianglong Biotech Co., Ltd.",
      "address_1": "North Of Baoan Road, East Of Changqing Street",
      "address_2": "Hulan District",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0380-2026",
      "product_description": "Semaglutide,  For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China.",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution",
      "recall_initiation_date": "20260213",
      "center_classification_date": "20260302",
      "report_date": "20260311",
      "code_info": "Batch # CP-030-20250911, Mfg Date: Sep. 25th, 2025, Retest Date: Sep. 24th, 2027."
    }
  ]
}